Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...

HealthDay News — No controlled studies report benefits of screening with multicancer detection (MCD) tests, according to a study published online Sept. 16 in the Annals of Internal Medicine.

Multiple versions of ChatGPT demonstrated efficacy in identifying eligible patients for clinical trial recruitment, showing ...

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

A meta-analysis of pediatric patients shows the potential promise of this noninvasive biomarker for early diagnosis, risk stratification, and management of nephrotic syndrome.

Greater baseline EASI scores and greater BMI are associated with poor response to lebrikizumab among patients with moderate to severe AD.

Introduction Safe surgical care is a cost-effective intervention for addressing a wide range of conditions, yet postoperative ...